Business OpportunityUpdated on 5 February 2026
Synthetic Health Data Generation for Privacy-Preserving AI in Precision Medicine and Population Health
CEO at findspo
Barcelona, Spain
About
Findspo is a European deeptech company specializing in artificial intelligence and synthetic data generation for health, aging and population-level decision support.
We support research groups, hospitals, SMEs and consortia working in precision medicine, chronic disease management and healthy aging, particularly in contexts where access to real-world clinical or multi-omic data is limited by privacy, fragmentation, bias or low incidence rates.
Our core capability is the generation of high-fidelity synthetic health data, designed to preserve the statistical and causal properties of real datasets while eliminating re-identification risks. We work with multiple data modalities, including:
-
Clinical and EHR-derived data
-
Multi-omic and biomarker data
-
Wearable and time-series data
-
Behavioral, lifestyle and population health data
Synthetic data is used to:
-
Augment small or imbalanced cohorts
-
Simulate rare events and disease trajectories
-
Enable cross-site and cross-country model validation
-
Support federated learning and EHDS-aligned architectures
-
Accelerate AI development without direct data sharing
Our approach combines GAN-based and hybrid generative models with explainable AI, ensuring that synthetic datasets are not only realistic, but also usable for clinical research, AI training and regulatory-compliant deployment.
Findspo actively collaborates in Horizon Europe, Digital Europe and health-related European consortia, contributing as a synthetic data, AI and implementation partner, with a strong focus on scalability, real-world impact and long-term sustainability.
We are open to collaborations involving:
-
Precision medicine and multimodal AI
-
Aging, prevention and population health
-
Chronic disease and remote monitoring
-
Health data spaces and privacy-preserving analytics
Stage
- TRL 6
Topic
- Bioinformatics
Sector
- Health data
Type
- Research collaboration
Attached files
Organisation
Similar opportunities
Business Opportunity
SmartCHF-AI – Smart Wearable and Federated AI Ecosystem for CHF Management
- AI
- TRL 7
- Licensing
- Diagnostics
- Cardiovascular
- Co-development
- Regulatory expert
- Clinical validation
- Consortium partners
- Research collaboration
Emmanouil Spanakis
COO, CIO at TRAQBEAT TECHNOLOGIES PC
Heraklion, Greece
Business Opportunity
Mediterranean Diet Impact on Clonal Hematopoiesis: A population-Based Study (MEDICH)
- AI
- TRL 6
- Other
- Other
- Genomics
- Proteomics
- Health data
- Bioinformatics
- Cardiovascular
- Co-development
- Consortium partners
- Research collaboration
- Neoplasms/cancer/oncology
- Diseases of the blood and immune disorders
Helen Papadaki
Professor of Hematology and Dean, School of Medicine, University of Crete, Greece at School of Medicine, University of Crete (UoCrete)
Heraklion, Greece
Business Opportunity
vitalera: Making Hospital-at-Home a Reality with AI
- AI
- TRL 8
- Oncology
- Physiology
- Pediatrics
- Licensing
- Respiratory
- Health data
- Rare diseases
- Rare diseases
- Bioinformatics
- Cardiovascular
- Co-development
- Digestive system
- Consortium partners
- Regenerative medicine
- Research collaboration
- External causes of morbidity, mortality
- Injury, poisoning, other external causes
- Pregnancy, childbirth and the puerperium
- Musculoskeletal system, connective tissue
- Other symptoms, deviant clinical findings
- Diseases of the blood and immune disorders
- Diseases of the nervous system / neurology
- Mental and behavioural disorders / psychiatry /psychology
Nuria Pastor
General Manager at vitalera
Barcelona, Spain